Crucell N.V.
Below you will find information from the register publication of inside information. The information has been provided by the organisation.
Registration date
12 aug 2008 - 12:33
Statutory name
Crucell N.V.
Title
Crucell Announces Second Quarter 2008 Results
Comments
Total revenue and other operating income increased by 51% to €59.6 million, compared to €39.4 million in the second quarter of 2007.
Solid gross margins of 36% and significantly reduced net loss for the second quarter to €7.9 million compared to €18.2 million in Q207.
2008 full year guidance reiterated: total revenue and other operating income growth of 20% in constant currencies[1]; higher margins; positive cash flow.
Leiden, The Netherlands (August 12, 2008) - Dutch biopharma company Crucell N.V. (Euronext, Nasdaq: CRXL; Swiss Exchange: CRX) today announced its financial results for the second quarter of 2008, based on International Financial Reporting Standards (IFRS). These financial results are unaudited.
Date last update: 05 May 2025